Evaluation of hepatic cystic lesions

World Journal of Gastroenterology

Volumn 19, Issue 23, 2013, Pages 3543-3554

  Lantinga, Marten A ^a   Gevers, Tom J G ^a   Drenth, Joost P H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Coincidental hepatic cystic lesions; Complicated cyst; Cystic liver disease; Diagnostic algorithm; Polycystic liver disease

Indexed keywords

ALGORITHM; CLINICAL DECISION MAKING; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; CYSTADENOCARCINOMA; CYSTADENOMA; DIFFERENTIAL DIAGNOSIS; ECHINOCOCCOSIS; ECHOGRAPHY; GENETIC DISORDER; HUMAN; KIDNEY POLYCYSTIC DISEASE; LIVER POLYCYSTIC DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; REVIEW; SERODIAGNOSIS;

EID: 84879180937     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i23.3543     Document Type: Review

References (123)

1. Cowles RA, Mulholland MW. Solitary hepatic cysts. J Am Coll Surg 2000; 191: 311-321 [PMID: 10989905 DOI: 10.1016/ S1072-7515(00)00345-8]
2. Del Poggio P, Buonocore M. Cystic tumors of the liver: a practical approach. World J Gastroenterol 2008; 14: 3616-3620 [PMID: 18595127 DOI: 10.3748/wjg.14.3616]
3. Bahirwani R, Reddy KR. Review article: the evaluation of solitary liver masses. Aliment Pharmacol Ther 2008; 28: 953-965 [PMID: 18643922 DOI: 10.1111/j.1365-2036.2008.03805.x]
4. Choi BY, Nguyen MH. The diagnosis and management of benign hepatic tumors. J Clin Gastroenterol 2005; 39: 401-412 [PMID: 15815209 DOI: 10.1097/01.mcg.0000159226.63037.a2]
5. Läuffer JM, Baer HU, Maurer CA, Stoupis C, Zimmerman A, Büchler MW. Biliary cystadenocarcinoma of the liver: the need for complete resection. Eur J Cancer 1998; 34: 1845-1851 [PMID: 10023304 DOI: 10.1016/S0959-8049(98)00166-X]
6. Nunnari G, Pinzone MR, Gruttadauria S, Celesia BM, Madeddu G, Malaguarnera G, Pavone P, Cappellani A, Cacopardo B. Hepatic echinococcosis: clinical and therapeutic aspects. World J Gastroenterol 2012; 18: 1448-1458 [PMID: 22509076 DOI: 10.3748/wjg.v18.i13.1448]
7. Eckert J, Deplazes P. Alveolar echinococcosis in humans: the current situation in Central Europe and the need for countermeasures. Parasitol Today 1999; 15: 315-319 [PMID: 10407377 DOI: 10.1016/S0169-4758(99)01476-3]
8. Romig T, Dinkel A, Mackenstedt U. The present situation of echinococcosis in Europe. Parasitol Int 2006; 55 Suppl: S187-S191 [PMID: 16352465 DOI: 10.1016/j.parint.2005.11.028]
9. Sanfelippo PM, Beahrs OH, Weiland LH. Cystic disease of the liver. Ann Surg 1974; 179: 922-925 [PMID: 4835513 DOI: 10.1097/00000658-197406000-00018]
10. Jones WL, Mountain JC, Warren KW. Symptomatic nonparasitic cysts of the liver. Br J Surg 1974; 61: 118-123 [PMID: 4816238 DOI: 10.1002/bjs.1800610211]
11. Gaines PA, Sampson MA. The prevalence and characterization of simple hepatic cysts by ultrasound examination. Br J Radiol 1989; 62: 335-337 [PMID: 2653548 DOI: 10.1259/0007-1 285-62-736-335]
12. Carrim ZI, Murchison JT. The prevalence of simple renal and hepatic cysts detected by spiral computed tomography. Clin Radiol 2003; 58: 626-629 [PMID: 12887956 DOI: 10.1016/S0009-9260(03)00165-X]
13. Hanazaki K, Wakabayashi M, Mori H, Sodeyama H, Yoshizawa K, Yokoyama S, Sode Y, Kawamura N, Miyazaki T. Hemorrhage into a simple liver cyst: diagnostic implications of a recent case. J Gastroenterol 1997; 32: 848-851 [PMID: 9430029 DOI: 10.1007/BF02936967]
14. Salemis NS, Georgoulis E, Gourgiotis S, Tsohataridis E. Spontaneous rupture of a giant non parasitic hepatic cyst presenting as an acute surgical abdomen. Ann Hepatol 2007; 6: 190-193 [PMID: 17786149]
15. Zhang YL, Yuan L, Shen F, Wang Y. Hemorrhagic hepatic cysts mimicking biliary cystadenoma. World J Gastroenterol 2009; 15: 4601-4603 [PMID: 19777623 DOI: 10.3748/ wjg.15.4601]
16. Kitajima Y, Okayama Y, Hirai M, Hayashi K, Imai H, Okamoto T, Aoki S, Akita S, Gotoh K, Ohara H, Nomura T, Joh T, Yokoyama Y, Itoh M. Intracystic hemorrhage of a simple liver cyst mimicking a biliary cystadenocarcinoma. J Gastroenterol 2003; 38: 190-193 [PMID: 12640536 DOI: 10.1007/ s005350300032]
17. Waanders E, van Keimpema L, Brouwer JT, van Oijen MG, Aerts R, Sweep FC, Nevens F, Drenth JP. Carbohydrate antigen 19-9 is extremely elevated in polycystic liver disease. Liver Int 2009; 29: 1389-1395 [PMID: 19515221 DOI: 10.1111/ j.1478-3231.2009.02055.x]
18. Choi HK, Lee JK, Lee KH, Lee KT, Rhee JC, Kim KH, Jang KT, Kim SH, Park Y. Differential diagnosis for intrahepatic biliary cystadenoma and hepatic simple cyst: significance of cystic fluid analysis and radiologic findings. J Clin Gastroenterol 2010; 44: 289-293 [PMID: 19770676 DOI: 10.1097/ MCG.0b013e3181b5c789]
19. Seo JK, Kim SH, Lee SH, Park JK, Woo SM, Jeong JB, Hwang JH, Ryu JK, Kim JW, Jeong SH, Kim YT, Yoon YB, Lee KU, Kim SH, Kim MA. Appropriate diagnosis of biliary cystic tumors: comparison with atypical hepatic simple cysts. Eur J Gastroenterol Hepatol 2010; 22: 989-996 [PMID: 20300006 DOI: 10.1097/MEG.0b013e328337c971]
20. Spiegel RM, King DL, Green WM. Ultrasonography of primary cysts of the liver. AJR Am J Roentgenol 1978; 131: 235-238 [PMID: 98001]
21. Vachha B, Sun MR, Siewert B, Eisenberg RL. Cystic lesions of the liver. AJR Am J Roentgenol 2011; 196: W355-W366 [PMID: 21427297 DOI: 10.2214/AJR.10.5292]
22. Albiin N. MRI of Focal Liver Lesions. Curr Med Imaging Rev 2012; 8: 107-116 [PMID: 23049491 DOI: 10.2174/157340512800 672216]
23. Taylor KJ, Richman TS. Diseases of the liver. Semin Roentgenol 1983; 18: 94-101 [PMID: 6306843 DOI: 10.1016/0037-198 X(83)90008-1]
24. Hwang SH, Yu JS, Chung JJ, Kim JH, Kim KW. Diagnosing small hepatic cysts on multidetector CT: an additional merit of thinner coronal reformations. Korean J Radiol 2011; 12: 341-350 [PMID: 21603293 DOI: 10.3348/kjr.2011.12.3.341]
25. Hagiwara A, Inoue Y, Shutoh T, Kinoshita H, Wakasa K. Haemorrhagic hepatic cyst: a differential diagnosis of cystic tumour. Br J Radiol 2001; 74: 270-272 [PMID: 11338106]
26. Yamaguchi M, Kuzume M, Matsumoto T, Matsumiya A, Nakano H, Kumada K. Spontaneous rupture of a nonparasitic liver cyst complicated by intracystic hemorrhage. J Gastroenterol 1999; 34: 645-648 [PMID: 10535497 DOI: 10.1007/ s005350050388]
27. Vilgrain V, Silbermann O, Benhamou JP, Nahum H. MR imaging in intracystic hemorrhage of simple hepatic cysts. Abdom Imaging 1993; 18: 164-167 [PMID: 8439758 DOI: 10.1007/ BF00198056]
28. Kim TK, Jang HJ, Wilson SR. Benign liver masses: imaging with microbubble contrast agents. Ultrasound Q 2006; 22: 31-39 [PMID: 16641791]
29. Jang HJ, Yu H, Kim TK. Contrast-enhanced ultrasound in the detection and characterization of liver tumors. Cancer Imaging 2009; 9: 96-103 [PMID: 19933022]
30. Sutherland T, Temple F, Lee WK, Hennessy O. Evaluation of focal hepatic lesions with ultrasound contrast agents. J Clin Ultrasound 2011; 39: 399-407 [PMID: 21674510 DOI: 10.1002/ jcu.20847]
31. Piscaglia F, Lencioni R, Sagrini E, Pina CD, Cioni D, Vidili G, Bolondi L. Characterization of focal liver lesions with contrast-enhanced ultrasound. Ultrasound Med Biol 2010; 36: 531-550 [PMID: 20350680 DOI: 10.1016/j.ultrasmedbio.2010.0 1.004]
32. van Keimpema L, de Koning DB, Strijk SP, Drenth JP. Aspiration-sclerotherapy results in effective control of liver volume in patients with liver cysts. Dig Dis Sci 2008; 53: 2251-2257 [PMID: 18299984 DOI: 10.1007/s10620-007-0121-x]
33. Moorthy K, Mihssin N, Houghton PW. The management of simple hepatic cysts: sclerotherapy or laparoscopic fenestration. Ann R Coll Surg Engl 2001; 83: 409-414 [PMID: 11777137]
34. Fiamingo P, Tedeschi U, Veroux M, Cillo U, Brolese A, Da Rold A, Madia C, Zanus G, D'Amico DF. Laparoscopic treatment of simple hepatic cysts and polycystic liver disease. Surg Endosc 2003; 17: 623-626 [PMID: 12574922]
35. Hansman MF, Ryan JA, Holmes JH, Hogan S, Lee FT, Kramer D, Biehl T. Management and long-term follow-up of hepatic cysts. Am J Surg 2001; 181: 404-410 [PMID: 11448430 DOI: 10.1016/S0002-9610(01)00611-0]
36. Gigot JF, Legrand M, Hubens G, de Canniere L, Wibin E, Deweer F, Druart ML, Bertrand C, Devriendt H, Droissart R, Tugilimana M, Hauters P, Vereecken L. Laparoscopic treatment of nonparasitic liver cysts: adequate selection of patients and surgical technique. World J Surg 1996; 20: 556-561 [PMID: 8661625 DOI: 10.1007/s002689900086]
37. Bristow BN, Lee S, Shafir S, Sorvillo F. Human echinococcosis mortality in the United States, 1990-2007. PLoS Negl Trop Dis 2012; 6: e1524 [PMID: 22347516 DOI: 10.1371/journal. pntd.0001524]
38. Budke CM, Deplazes P, Torgerson PR. Global socioeconomic impact of cystic echinococcosis. Emerg Infect Dis 2006; 12: 296-303 [PMID: 16494758 DOI: 10.3201/eid1202.050499]
39. Dakkak A. Echinococcosis/hydatidosis: a severe threat in Mediterranean countries. Vet Parasitol 2010; 174: 2-11 [PMID: 20888694 DOI: 10.1016/j.vetpar.2010.08.009]
40. Torgerson PR, Keller K, Magnotta M, Ragland N. The global burden of alveolar echinococcosis. PLoS Negl Trop Dis 2010; 4: e722 [PMID: 20582310 DOI: 10.1371/journal.pntd.0000722]
41. Eckert J, Conraths FJ, Tackmann K. Echinococcosis: an emerging or re-emerging zoonosis? Int J Parasitol 2000; 30: 1283-1294 [PMID: 11113255 DOI: 10.1016/S0020-7519(00)00130-2]
42. Grosso G, Gruttadauria S, Biondi A, Marventano S, Mistretta A. Worldwide epidemiology of liver hydatidosis including the Mediterranean area. World J Gastroenterol 2012; 18: 1425-1437 [PMID: 22509074 DOI: 10.3748/wjg.v18.i13.1425]
43. Todorov T, Boeva V. Human echinococcosis in Bulgaria: a comparative epidemiological analysis. Bull World Health Organ 1999; 77: 110-118 [PMID: 10083708]
44. Mandal S, Mandal MD. Human cystic echinococcosis: epidemiologic, zoonotic, clinical, diagnostic and therapeutic aspects. Asian Pac J Trop Med 2012; 5: 253-260 [PMID: 22449514 DOI: 10.1016/S1995-7645(12)60035-2]
45. McManus DP, Zhang W, Li J, Bartley PB. Echinococcosis. Lancet 2003; 362: 1295-1304 [PMID: 14575976 DOI: 10.1016/ S0140-6736(03)14573-4]
46. Craig PS, Larrieu E. Control of cystic echinococcosis/hydatidosis: 1863-2002. Adv Parasitol 2006; 61: 443-508 [PMID: 16735171 DOI: 10.1016/S0065-308X(05)61011-1]
47. Eckert J. WHO/OIE manual on echinococcosis in humans and animals: a public health problem of global concern. Paris: World Organisation for Animal Health, 2001: 20-72
48. Sayek I, Onat D. Diagnosis and treatment of uncomplicated hydatid cyst of the liver. World J Surg 2001; 25: 21-27 [PMID: 11213152 DOI: 10.1007/s002680020004]
49. Sbihi Y, Rmiqui A, Rodriguez-Cabezas MN, Orduña A, Rodriguez-Torres A, Osuna A. Comparative sensitivity of six serological tests and diagnostic value of ELISA using purified antigen in hydatidosis. J Clin Lab Anal 2001; 15: 14-18 [PMID: 11170228 DOI: 10.1002/1098-2825(2001)15:]
50. Brunetti E, Junghanss T. Update on cystic hydatid disease. Curr Opin Infect Dis 2009; 22: 497-502 [PMID: 19633552 DOI: 10.1097/QCO.0b013e328330331c]
51. Buttenschoen K, Carli Buttenschoen D. Echinococcus granulosus infection: the challenge of surgical treatment. Langenbecks Arch Surg 2003; 388: 218-230 [PMID: 12845535 DOI: 10.1007/s00423-003-0397-z]
52. Smego RA, Sebanego P. Treatment options for hepatic cystic echinococcosis. Int J Infect Dis 2005; 9: 69-76 [PMID: 15708321 DOI: 10.1016/j.ijid.2004.08.001]
53. Eckert J, Deplazes P. Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern. Clin Microbiol Rev 2004; 17: 107-135 [PMID: 14726458 DOI: 10.1128/CMR.17.1.107-135.2004]
54. Moro P, Schantz PM. Echinococcosis: a review. Int J Infect Dis 2009; 13: 125-133 [PMID: 18938096 DOI: 10.1016/ j.ijid.2008.03.037]
55. Kern P. Clinical features and treatment of alveolar echinococ-cosis. Curr Opin Infect Dis 2010; 23: 505-512 [PMID: 20683265 DOI: 10.1097/QCO.0b013e32833d7516]
56. Takci E, Sengul G, Akar A, Uslu H, Alper F, Erdogan F, Aydin IH. Alveolar echinococcosis of the brain in five patients. J Clin Neurosci 2008; 15: 1105-1109 [PMID: 18653340 DOI: 10.1016/j.jocn.2007.09.020]
57. Bresson-Hadni S, Delabrousse E, Blagosklonov O, Bartholomot B, Koch S, Miguet JP, André Mantion G, Angèle Vuitton D. Imaging aspects and non-surgical interventional treatment in human alveolar echinococcosis. Parasitol Int 2006; 55 Suppl: S267-S272 [PMID: 16403670 DOI: 10.1016/j.parint.2005.11.053]
58. Kodama Y, Fujita N, Shimizu T, Endo H, Nambu T, Sato N, Todo S, Miyasaka K. Alveolar echinococcosis: MR findings in the liver. Radiology 2003; 228: 172-177 [PMID: 12750459 DOI: 10.1148/radiol.2281020323]
59. Harman M, Arslan H, Kotan C, Etlik O, Kayan M, Deveci A. MRI findings of hepatic alveolar echinococcosis. Clin Imaging 2003; 27: 411-416 [PMID: 14585571 DOI: 10.1016/ S0899-7071(03)00006-8]
60. Brunetti E, Kern P, Vuitton DA. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop 2010; 114: 1-16 [PMID: 19931502 DOI: 10.1016/j.actatropica.2009.11.001]
61. Buttenschoen K, Carli Buttenschoen D, Gruener B, Kern P, Beger HG, Henne-Bruns D, Reuter S. Long-term experience on surgical treatment of alveolar echinococcosis. Langenbecks Arch Surg 2009; 394: 689-698 [PMID: 18651165 DOI: 10.1007/ s00423-008-0392-5]
62. Delis SG, Touloumis Z, Bakoyiannis A, Tassopoulos N, Paraskeva K, Athanassiou K, Safioleas M, Dervenis C. Intrahepatic biliary cystadenoma: a need for radical resection. Eur J Gastroenterol Hepatol 2008; 20: 10-14 [PMID: 18090983 DOI: 10.1097/MEG.0b013e3282f16a76]
63. Hai S, Hirohashi K, Uenishi T, Yamamoto T, Shuto T, Tanaka H, Kubo S, Tanaka S, Kinoshita H. Surgical management of cystic hepatic neoplasms. J Gastroenterol 2003; 38: 759-764 [PMID: 14505130 DOI: 10.1007/s00535-003-1142-7]
64. Wheeler DA, Edmondson HA. Cystadenoma with mesenchymal stroma (CMS) in the liver and bile ducts. A clinicopathologic study of 17 cases, 4 with malignant change. Cancer 1985; 56: 1434-1445 [PMID: 4027877 DOI: 10.1002/1097-0142(19850915)56:]
65. Devaney K, Goodman ZD, Ishak KG. Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients. Am J Surg Pathol 1994; 18: 1078-1091 [PMID: 7943529 DOI: 10.1097/00000478-1 99411000-00002]
66. Hernandez Bartolome MA, Fuerte Ruiz S, Manzanedo Romero I, Ramos Lojo B, Rodriguez Prieto I, Gimenez Alvira L, Granados Carreño R, Limones Esteban M. Biliary cystadenoma. World J Gastroenterol 2009; 15: 3573-3575 [PMID: 19630118 DOI: 10.3748/wjg.15.3573]
67. Yi B, Cheng QB, Jiang XQ, Liu C, Luo XJ, Dong H, Zhang BH, Wu MC. A special growth manner of intrahepatic biliary cystadenoma. World J Gastroenterol 2009; 15: 6134-6136 [PMID: 20027691 DOI: 10.3748/wjg.15.6134]
68. Kim HG. [Biliary cystic neoplasm: biliary cystadenoma and biliary cystadenocarcinoma]. Korean J Gastroenterol 2006; 47: 5-14 [PMID: 16434863]
69. Ahanatha Pillai S, Velayutham V, Perumal S, Ulagendra Perumal S, Lakshmanan A, Ramaswami S, Ramasamy R, Sathyanesan J, Palaniappan R, Rajagopal S. Biliary cystadenomas: a case for complete resection. HPB Surg 2012; 2012: 501705 [PMID: 22778493 DOI: 10.1155/2012/501705]
70. Teoh AY, Ng SS, Lee KF, Lai PB. Biliary cystadenoma and other complicated cystic lesions of the liver: diagnostic and therapeutic challenges. World J Surg 2006; 30: 1560-1566 [PMID: 16865321 DOI: 10.1007/s00268-005-0461-7]
71. Taouli B, Koh DM. Diffusion-weighted MR imaging of the liver. Radiology 2010; 254: 47-66 [PMID: 20032142 DOI: 10.1148/radiol.09090021]
72. Yamada I, Aung W, Himeno Y, Nakagawa T, Shibuya H. Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-planar MR imaging. Radiology 1999; 210: 617-623 [PMID: 10207458]
73. Inan N, Arslan A, Akansel G, Anik Y, Sarisoy HT, Ciftci E, Demirci A. Diffusion-weighted imaging in the differential diagnosis of simple and hydatid cysts of the liver. AJR Am J Roentgenol 2007; 189: 1031-1036 [PMID: 17954636 DOI: 10.2214/AJR.07.2251]
74. Fowler KJ, Brown JJ, Narra VR. Magnetic resonance imaging of focal liver lesions: approach to imaging diagnosis. Hepatology 2011; 54: 2227-2237 [PMID: 21932400 DOI: 10.1002/ hep.24679]
75. Kele PG, van der Jagt EJ. Diffusion weighted imaging in the liver. World J Gastroenterol 2010; 16: 1567-1576 [PMID: 20355235 DOI: 10.3748/wjg.v16.i13.1567]
76. Pinto MM, Kaye AD. Fine needle aspiration of cystic liver lesions. Cytologic examination and carcinoembryonic antigen assay of cyst contents. Acta Cytol 1989; 33: 852-856 [PMID: 2686325]
77. Van Keimpema L, De Koning DB, Van Hoek B, Van Den Berg AP, Van Oijen MG, De Man RA, Nevens F, Drenth JP. Patients with isolated polycystic liver disease referred to liver centres: clinical characterization of 137 cases. Liver Int 2011; 31: 92-98 [PMID: 20408955 DOI: 10.1111/ j.1478-3231.2010.02247.x]
78. Drenth JP, Chrispijn M, Bergmann C. Congenital fibrocystic liver diseases. Best Pract Res Clin Gastroenterol 2010; 24: 573-584 [PMID: 20955960 DOI: 10.1016/j.bpg.2010.08.007]
79. Hoevenaren IA, Wester R, Schrier RW, McFann K, Doctor RB, Drenth JP, Everson GT. Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease. Liver Int 2008; 28: 264-270 [PMID: 17927714 DOI: 10.1111/j.1478-3231.2007.01595.x]
80. Brancatelli G, Federle MP, Vilgrain V, Vullierme MP, Marin D, Lagalla R. Fibropolycystic liver disease: CT and MR imaging findings. Radiographics 2005; 25: 659-670 [PMID: 15888616 DOI: 10.1148/rg.253045114]
81. Roskams T, Desmet V. Embryology of extra-and intrahepatic bile ducts, the ductal plate. Anat Rec (Hoboken) 2008; 291: 628-635 [PMID: 18484608 DOI: 10.1002/ar.20710]
82. Desmet VJ. Ludwig symposium on biliary disorders--part I. Pathogenesis of ductal plate abnormalities. Mayo Clin Proc 1998; 73: 80-89 [PMID: 9443684 DOI: 10.4065/73.1.80]
83. Patterson M, Gonzalez-Vitale JC, Fagan CJ. Polycystic liver disease: a study of cyst fluid constituents. Hepatology 1982; 2: 475-478 [PMID: 7095747 DOI: 10.1002/hep.1840020414]
84. Torres VE, Watson ML. Polycystic kidney disease: antiquity to the 20th century. Nephrol Dial Transplant 1998; 13: 2690-2696 [PMID: 9794593 DOI: 10.1093/ndt/13.10.2690]
85. Karhunen PJ, Tenhu M. Adult polycystic liver and kidney diseases are separate entities. Clin Genet 1986; 30: 29-37 [PMID: 3757294 DOI: 10.1111/j.1399-0004.1986.tb00565.x]
86. Pirson Y, Lannoy N, Peters D, Geubel A, Gigot JF, Breuning M, Verellen-Dumoulin C. Isolated polycystic liver disease as a distinct genetic disease, unlinked to polycystic kidney disease 1 and polycystic kidney disease 2. Hepatology 1996; 23: 249-252 [PMID: 8591848 DOI: 10.1053/jhep.1996.v23. pm0008591848]
87. Harris PC, Torres VE. Polycystic kidney disease. Annu Rev Med 2009; 60: 321-337 [PMID: 18947299 DOI: 10.1146/annurev. med.60.101707.125712]
88. Davila S, Furu L, Gharavi AG, Tian X, Onoe T, Qian Q, Li A, Cai Y, Kamath PS, King BF, Azurmendi PJ, Tahvanainen P, Kääriäinen H, Höckerstedt K, Devuyst O, Pirson Y, Martin RS, Lifton RP, Tahvanainen E, Torres VE, Somlo S. Mutations in SEC63 cause autosomal dominant polycystic liver disease. Nat Genet 2004; 36: 575-577 [PMID: 15133510 DOI: 10.1038/ ng1357]
89. Drenth JP, te Morsche RH, Smink R, Bonifacino JS, Jansen JB. Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease. Nat Genet 2003; 33: 345-347 [PMID: 12577059 DOI: 10.1038/ng1104]
90. Li A, Davila S, Furu L, Qian Q, Tian X, Kamath PS, King BF, Torres VE, Somlo S. Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease. Am J Hum Genet 2003; 72: 691-703 [PMID: 12529853 DOI: 10.1086/368295]
91. Waanders E, Venselaar H, te Morsche RH, de Koning DB, Kamath PS, Torres VE, Somlo S, Drenth JP. Secondary and tertiary structure modeling reveals effects of novel mutations in polycystic liver disease genes PRKCSH and SEC63. Clin Genet 2010; 78: 47-56 [PMID: 20095989 DOI: 10.1111/ j.1399-0004.2009.01353.x]
92. Rossetti S, Consugar MB, Chapman AB, Torres VE, Guay-Woodford LM, Grantham JJ, Bennett WM, Meyers CM, Walker DL, Bae K, Zhang QJ, Thompson PA, Miller JP, Harris PC. Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2007; 18: 2143-2160 [PMID: 17582161 DOI: 10.1681/ ASN.2006121387]
93. Janssen MJ, Waanders E, Woudenberg J, Lefeber DJ, Drenth JP. Congenital disorders of glycosylation in hepatology: the example of polycystic liver disease. J Hepatol 2010; 52: 432-440 [PMID: 20138683 DOI: 10.1016/j.jhep.2009.12.011]
94. Yoder BK, Mulroy S, Eustace H, Boucher C, Sandford R. Molecular pathogenesis of autosomal dominant polycystic kidney disease. Expert Rev Mol Med 2006; 8: 1-22 [PMID: 16515728 DOI: 10.1017/S1462399406010362]
95. Qian Q. Isolated polycystic liver disease. Adv Chronic Kidney Dis 2010; 17: 181-189 [PMID: 20219621 DOI: 10.1053/ j.ackd.2009.12.005]
96. Torres VE, Harris PC. Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int 2009; 76: 149-168 [PMID: 19455193 DOI: 10.1038/ki.2009.128]
97. Perrone RD. Extrarenal manifestations of ADPKD. Kidney Int 1997; 51: 2022-2036 [PMID: 9186898 DOI: 10.1038/ki.1997.276]
98. Harris PC, Bae KT, Rossetti S, Torres VE, Grantham JJ, Chapman AB, Guay-Woodford LM, King BF, Wetzel LH, Baumgarten DA, Kenney PJ, Consugar M, Klahr S, Bennett WM, Meyers CM, Zhang QJ, Thompson PA, Zhu F, Miller JP. Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2006; 17: 3013-3019 [PMID: 17035604 DOI: 10.1681/ASN.2006080835]
99. Qian Q, Li A, King BF, Kamath PS, Lager DJ, Huston J, Shub C, Davila S, Somlo S, Torres VE. Clinical profile of autosomal dominant polycystic liver disease. Hepatology 2003; 37: 164-171 [PMID: 12500201 DOI: 10.1053/jhep.2003.50006]
100. Pirson Y. Extrarenal manifestations of autosomal dominant polycystic kidney disease. Adv Chronic Kidney Dis 2010; 17: 173-180 [PMID: 20219620 DOI: 10.1053/j.ackd.2010.01.003]
101. Bae KT, Zhu F, Chapman AB, Torres VE, Grantham JJ, Guay-Woodford LM, Baumgarten DA, King BF, Wetzel LH, Kenney PJ, Brummer ME, Bennett WM, Klahr S, Meyers CM, Zhang X, Thompson PA, Miller JP. Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort. Clin J Am Soc Nephrol 2006; 1: 64-69 [PMID: 17699192 DOI: 10.2215/ CJN.00080605]
102. Pei Y, Watnick T. Diagnosis and screening of autosomal dominant polycystic kidney disease. Adv Chronic Kidney Dis 2010; 17: 140-152 [PMID: 20219617 DOI: 10.1053/j.ackd.2009.12.001]
103. Alvaro D, Mancino MG, Onori P, Franchitto A, Alpini G, Francis H, Glaser S, Gaudio E. Estrogens and the pathophysiology of the biliary tree. World J Gastroenterol 2006; 12: 3537-3545 [PMID: 16773710]
104. Hateboer N, Dijk MA, Bogdanova N, Coto E, Saggar-Malik AK, San Millan JL, Torra R, Breuning M, Ravine D. Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group. Lancet 1999; 353: 103-107 [PMID: 10023895 DOI: 10.1016/S0140-6736(98)03495-3]
105. Gabow PA, Johnson AM, Kaehny WD, Manco-Johnson ML, Duley IT, Everson GT. Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease. Hepatology 1990; 11: 1033-1037 [PMID: 2365280 DOI: 10.1002/ hep.1840110619]
106. Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet 2007; 369: 1287-1301 [PMID: 17434405 DOI: 10.1016/S0140-6736(07)60601-1]
107. Que F, Nagorney DM, Gross JB, Torres VE. Liver resection and cyst fenestration in the treatment of severe polycystic liver disease. Gastroenterology 1995; 108: 487-494 [PMID: 7835591 DOI: 10.1016/0016-5085(95)90078-0]
108. Belibi FA, Edelstein CL. Unified ultrasonographic diagnostic criteria for polycystic kidney disease. J Am Soc Nephrol 2009; 20: 6-8 [PMID: 19073819 DOI: 10.1681/ASN.2008111164]
109. Nicolau C, Torra R, Badenas C, Vilana R, Bianchi L, Gilabert R, Darnell A, Brú C. Autosomal dominant polycystic kidney disease types 1 and 2: assessment of US sensitivity for diagnosis. Radiology 1999; 213: 273-276 [PMID: 10540671]
110. Pei Y, Obaji J, Dupuis A, Paterson AD, Magistroni R, Dicks E, Parfrey P, Cramer B, Coto E, Torra R, San Millan JL, Gibson R, Breuning M, Peters D, Ravine D. Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol 2009; 20: 205-212 [PMID: 18945943 DOI: 10.1681/ASN.2008050507]
111. Ravine D, Gibson RN, Walker RG, Sheffield LJ, Kincaid-Smith P, Danks DM. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 1994; 343: 824-827 [PMID: 7908078 DOI: 10.1016/ S0140-6736(94)92026-5]
112. Ecder T, Schrier RW. Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease. Nat Rev Nephrol 2009; 5: 221-228 [PMID: 19322187 DOI: 10.1038/nrneph. 2009.13]
113. Schrier RW. Optimal care of autosomal dominant polycystic kidney disease patients. Nephrology (Carlton) 2006; 11: 124-130 [PMID: 16669974 DOI: 10.1111/j.1440-1797.2006.00535.x]
114. Gevers TJ, de Koning DB, van Dijk AP, Drenth JP. Low prevalence of cardiac valve abnormalities in patients with autosomal dominant polycystic liver disease. Liver Int 2012; 32: 690-692 [PMID: 22099398 DOI: 10.1111/ j.1478-3231.2011.02683.x]
115. Drenth JP, Chrispijn M, Nagorney DM, Kamath PS, Torres VE. Medical and surgical treatment options for polycystic liver disease. Hepatology 2010; 52: 2223-2230 [PMID: 21105111]
116. Temmerman F, Missiaen L, Bammens B, Laleman W, Cassiman D, Verslype C, van Pelt J, Nevens F. Systematic review: the pathophysiology and management of polycystic liver disease. Aliment Pharmacol Ther 2011; 34: 702-713 [PMID: 21790682 DOI: 10.1111/j.1365-2036.2011.04783.x]
117. Russell RT, Pinson CW. Surgical management of polycystic liver disease. World J Gastroenterol 2007; 13: 5052-5059 [PMID: 17876869]
118. Gevers TJ, Drenth JP. Somatostatin analogues for treatment of polycystic liver disease. Curr Opin Gastroenterol 2011; 27: 294-300 [PMID: 21191289 DOI: 10.1097/ MOG.0b013e328343433f]
119. van Keimpema L, Nevens F, Vanslembrouck R, van Oijen MG, Hoffmann AL, Dekker HM, de Man RA, Drenth JP. Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial. Gastroenterology 2009; 137: 1661-8. e1-2 [PMID: 19646443 DOI: 10.1053/ j.gastro.2009.07.052]
120. Caroli A, Antiga L, Cafaro M, Fasolini G, Remuzzi A, Remuzzi G, Ruggenenti P. Reducing polycystic liver volume in ADPKD: effects of somatostatin analogue octreotide. Clin J Am Soc Nephrol 2010; 5: 783-789 [PMID: 20185596 DOI: 10.2215/CJN.05380709]
121. Hogan MC, Masyuk TV, Page LJ, Kubly VJ, Bergstralh EJ, Li X, Kim B, King BF, Glockner J, Holmes DR, Rossetti S, Harris PC, LaRusso NF, Torres VE. Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease. J Am Soc Nephrol 2010; 21: 1052-1061 [PMID: 20431041 DOI: 10.1681/ASN.2009121291]
122. Hogan MC, Masyuk TV, Page L, Holmes DR, Li X, Bergstralh EJ, Irazabal MV, Kim B, King BF, Glockner JF, Larusso NF, Torres VE. Somatostatin analog therapy for severe polycystic liver disease: results after 2 years. Nephrol Dial Transplant 2012; 27: 3532-3539 [PMID: 22773240 DOI: 10.1093/ndt/ gfs152]
123. Chrispijn M, Drenth JP. Everolimus and long acting octreotide as a volume reducing treatment of polycystic livers (ELATE): study protocol for a randomized controlled trial. Trials 2011; 12: 246 [PMID: 22104015 DOI: 10.1186/1745-6215-12-246]